281 related articles for article (PubMed ID: 37152001)
1. Human arginase I: a potential broad-spectrum anti-cancer agent.
Anakha J; Prasad YR; Sharma N; Pande AH
3 Biotech; 2023 May; 13(5):159. PubMed ID: 37152001
[TBL] [Abstract][Full Text] [Related]
2. Targeting arginine metabolism pathway to treat arginine-dependent cancers.
Qiu F; Huang J; Sui M
Cancer Lett; 2015 Aug; 364(1):1-7. PubMed ID: 25917076
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of fused human arginase I for cancer therapy.
Jawalekar SS; Kawathe PS; Sharma N; Anakha J; Tikoo K; Pande AH
Invest New Drugs; 2023 Oct; 41(5):652-663. PubMed ID: 37532976
[TBL] [Abstract][Full Text] [Related]
4. Deprivation of arginine by recombinant human arginase in prostate cancer cells.
Hsueh EC; Knebel SM; Lo WH; Leung YC; Cheng PN; Hsueh CT
J Hematol Oncol; 2012 Apr; 5():17. PubMed ID: 22546217
[TBL] [Abstract][Full Text] [Related]
5. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cells.
Zeng X; Li Y; Fan J; Zhao H; Xian Z; Sun Y; Wang Z; Wang S; Zhang G; Ju D
Cell Death Dis; 2013 Oct; 4(10):e840. PubMed ID: 24113174
[TBL] [Abstract][Full Text] [Related]
8. A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor.
Shen W; Zhang X; Fu X; Fan J; Luan J; Cao Z; Yang P; Xu Z; Ju D
Cell Death Dis; 2017 Mar; 8(3):e2720. PubMed ID: 28358368
[TBL] [Abstract][Full Text] [Related]
9. Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells.
Wang Z; Shi X; Li Y; Fan J; Zeng X; Xian Z; Wang Z; Sun Y; Wang S; Song P; Zhao S; Hu H; Ju D
Cell Death Dis; 2014 Dec; 5(12):e1563. PubMed ID: 25501824
[TBL] [Abstract][Full Text] [Related]
10. The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma.
Lin C; Wang Z; Li L; He Y; Fan J; Liu Z; Zhao S; Ju D
Appl Microbiol Biotechnol; 2015 Oct; 99(20):8487-94. PubMed ID: 25904129
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.
Lam TL; Wong GK; Chow HY; Chong HC; Chow TL; Kwok SY; Cheng PN; Wheatley DN; Lo WH; Leung YC
Pigment Cell Melanoma Res; 2011 Apr; 24(2):366-76. PubMed ID: 21029397
[TBL] [Abstract][Full Text] [Related]
12. Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase.
Li Y; Zeng X; Wang S; Fan J; Wang Z; Song P; Mei X; Ju D
Tumour Biol; 2016 May; 37(5):6627-35. PubMed ID: 26643895
[TBL] [Abstract][Full Text] [Related]
13. Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells.
Wang Z; Shi X; Li Y; Zeng X; Fan J; Sun Y; Xian Z; Zhang G; Wang S; Hu H; Ju D
Appl Microbiol Biotechnol; 2014 Mar; 98(6):2485-94. PubMed ID: 23917632
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human arginase I elicited immunosuppression in activated macrophages through inhibiting autophagy.
Wang Z; Song P; Li Y; Wang S; Fan J; Zhang X; Luan J; Chen W; Wang Y; Liu P; Ju D
Appl Microbiol Biotechnol; 2019 Jun; 103(12):4825-4838. PubMed ID: 31053913
[TBL] [Abstract][Full Text] [Related]
15. Microbial enzymes for deprivation of amino acid metabolism in malignant cells: biological strategy for cancer treatment.
Dhankhar R; Gupta V; Kumar S; Kapoor RK; Gulati P
Appl Microbiol Biotechnol; 2020 Apr; 104(7):2857-2869. PubMed ID: 32037468
[TBL] [Abstract][Full Text] [Related]
16. Arginine deprivation as a strategy for cancer therapy: An insight into drug design and drug combination.
Zhang Y; Chung SF; Tam SY; Leung YC; Guan X
Cancer Lett; 2021 Apr; 502():58-70. PubMed ID: 33429005
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.
Nasreddine G; El-Sibai M; Abi-Habib RJ
Invest New Drugs; 2020 Feb; 38(1):10-19. PubMed ID: 30887252
[TBL] [Abstract][Full Text] [Related]
19. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
Kuo MT; Savaraj N; Feun LG
Oncotarget; 2010 Aug; 1(4):246-51. PubMed ID: 21152246
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Alexandrou C; Al-Aqbi SS; Higgins JA; Boyle W; Karmokar A; Andreadi C; Luo JL; Moore DA; Viskaduraki M; Blades M; Murray GI; Howells LM; Thomas A; Brown K; Cheng PN; Rufini A
Sci Rep; 2018 Aug; 8(1):12096. PubMed ID: 30108309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
